Chart calendar Perspective Therapeutics, Inc.

896e90.xV4wkL61ZMuXaEivDR-SQCDKFc4ZALk9bDscBdAzyHs.jjdz9PHEFf7tLBjpRUqhCVW9UZRrdPMMAVNyZuFL8BymH1zejZg1nfxcBQ~0173067d71c8fa0fdaf56adefd67c254

Upcoming events on Perspective Therapeutics, Inc.

No events available

Past events on Perspective Therapeutics, Inc.

2026-08-10

Earnings release - Q2 2026

2026-05-27

Annual General Meeting

10:00 am
2026-05-11

Earnings release - Q1 2026

2026-05-04

Présentation aux Actionnaires / Analystes

08:30 am
2026-03-16

Earnings release - Annual 2025

2025-11-10

Earnings release - Q3 2025

2025-10-20

Information meeting

08:30 am

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
1,43
8,46
-83.04%
1,45
1,46
-0.34%
0,88
1,07
-17.46%

0,30


0,37


0,35

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
-64,5
-62,5
-3.18%
-110
-102
-8.35%

-125


-139


-145

EBIT
Million USD
Released
Forecast
Spread
-40,9
-43,4
5.6%
-66,8
-67,1
0.48%
-114
-103
-9.76%

-124


-143


-154

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-40,1
-43,0
6.64%
-80,4
-58,1
-38.42%
-104
-95,1
-9.84%

-114


-137


-144

Net income
Million USD
Released
Forecast
Spread
-46,5
-37,7
-23.33%
-79,3
-58,0
-36.62%
-103
-94,1
-9.57%

-114


-136


-147

EPS
USD
Released
Forecast
Spread
-1,70
-1,40
-21.43%
-1,23
-0,66
-87.27%
-1,40
-1,25
-11.82%

-1,00


-1,06


-1,05

Announcement Date28/03/2426/03/2516/03/26-

Quarterly results

Fiscal PeriodJune 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
0,23
0,28
-15.61%
0,34
0,14
137.62%
0,29
0,17
70.22%
0,21
0,21
1.04%
0,04
0,24
-81.86%
0,08
0,14
-44.6%
0,08
0,09
-12.39%

0,05


0,05


0,05


0,01


0,01


0,01

EBITDA
Million USD
Released
Forecast
Spread
-20,2
-17,6
-14.42%
-21,1
-19,5
-7.96%
-23,3
-19,8
-17.54%
-27,1
-21,7
-24.85%
-38,8
-25,5
-52.26%
-27,2
-39,7
31.6%
-28,1
-29,2
3.72%

-34,0


-43,7













EBIT
Million USD
Released
Forecast
Spread
-20,9
-21,2
1.47%
-21,8
-23,0
5.05%
-24,0
-24,0
-0.28%
-27,9
-26,0
-7.32%
-39,8
-29,7
-33.98%
-28,3
-33,9
16.5%
-29,3
-30,5
4.08%

-31,5


-33,8


-33,0


-34,3


-35,4


-36,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-41,3
-18,6
-122.37%
-18,2
-22,4
18.96%
-22,0
-22,5
2.33%
-26,0
-24,6
-5.7%
-38,3
-29,0
-31.92%
-26,2
-32,0
18.19%
-27,0
-29,1
7.27%

-29,7


-31,5


-31,6


-33,0


-34,5


-35,8

Net income
Million USD
Released
Forecast
Spread
-40,2
-18,5
-116.65%
-18,2
-22,4
18.96%
-21,5
-22,1
2.64%
-26,0
-24,4
-6.41%
-37,5
-28,3
-32.38%
-26,2
-32,2
18.77%
-26,8
-29,0
7.78%

-29,7


-32,1


-31,4


-32,9


-34,5


-35,9

EPS
USD
Released
Forecast
Spread
-0,61
-0,24
-152.55%
-0,25
-0,31
18.34%
-0,29
-0,30
2.08%
-0,35
-0,32
-7.88%
-0,51
-0,36
-40.94%
-0,25
-0,30
17.03%
-0,22
-0,26
14.27%

-0,25


-0,26


-0,26


-0,27


-0,27


-0,28

Announcement Date26/03/2512/05/2513/08/2510/11/2516/03/2611/05/2610/08/26------
2026-10-06

Information meeting

2026-10-06

Analyst/Investor Day

11:00 am
2026-10-12

Analyst/Investor Day

2026-10-12

Extraordinary General Meeting

10:00 pm
2026-10-13

Earnings presentation

10:00 pm
2026-10-14

Analyst/Investor Day

12:00 pm
2026-10-20

Information meeting

08:30 am
2026-10-20

Analyst/Investor Day

2026-10-21

Earnings release - Q3 2026

2026-10-22

Earnings presentation

09:00 am

Past sector events for Perspective Therapeutics, Inc.

Today

Information meeting

08:30 am
Today

Extraordinary General Meeting

10:00 pm
2026-09-29

Earnings release - Q2 2026

2026-09-28

Extraordinary General Meeting

02:30 am
2026-09-28

Extraordinary General Meeting

02:30 am
2026-09-24

Analyst/Investor Day

09:00 am
2026-09-24

Information meeting

08:00 am
2026-09-23

Extraordinary General Meeting

09:00 am
2026-09-23

Présentation aux Actionnaires / Analystes

09:00 am
2026-09-23

Extraordinary General Meeting

03:00 am

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CATX Stock
  4. Calendar Perspective Therapeutics, Inc.